Anavex Life Sciences (AVXL) Share-based Compensation (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -84.73% |
| Sep 30, 2025 | 67.65% |
| Jun 30, 2025 | 198.41% |
| Mar 31, 2025 | -29.49% |
| Dec 31, 2024 | -70.38% |
| Sep 30, 2024 | -6.24% |
| Jun 30, 2024 | 179.03% |
| Mar 31, 2024 | 16.01% |
| Dec 31, 2023 | -28.94% |
| Sep 30, 2023 | -16.79% |
| Jun 30, 2023 | -2.62% |
| Mar 31, 2023 | -25.75% |
| Dec 31, 2022 | -11.81% |
| Sep 30, 2022 | 52.01% |
| Jun 30, 2022 | -10.16% |
| Mar 31, 2022 | 13.58% |
| Dec 31, 2021 | 25.26% |
| Sep 30, 2021 | 36.04% |
| Jun 30, 2021 | 24.25% |
| Mar 31, 2021 | 96.54% |
| Dec 31, 2020 | 42.19% |
| Sep 30, 2020 | -47.20% |
| Jun 30, 2020 | -26.44% |
| Mar 31, 2020 | 34.51% |
| Dec 31, 2019 | 2.26% |
| Sep 30, 2019 | 0.19% |
| Jun 30, 2019 | -34.81% |
| Mar 31, 2019 | -8.41% |
| Dec 31, 2018 | 38.58% |
| Sep 30, 2018 | -11.09% |
| Jun 30, 2018 | 36.88% |
| Mar 31, 2018 | 9.24% |
| Dec 31, 2017 | 0.38% |
| Sep 30, 2017 | -3.62% |
| Jun 30, 2017 | 19.69% |
| Mar 31, 2017 | 8.95% |
| Dec 31, 2016 | -76.51% |
| Sep 30, 2016 | 1,544.07% |
| Jun 30, 2016 | 3.39% |
| Mar 31, 2016 | -73.04% |
| Dec 31, 2015 | -39.64% |
| Sep 30, 2015 | 12,029.06% |
| Dec 31, 2014 | -97.56% |
| Sep 30, 2014 | 6,452.67% |
| Jun 30, 2012 | 23.28% |
| Mar 31, 2012 | -34.98% |
| Dec 31, 2011 | -52.18% |
| Sep 30, 2011 | 61.92% |
| Jun 30, 2011 | -76.19% |
| Mar 31, 2011 | 256.05% |
| Dec 31, 2010 | 28.67% |